The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years

Objectives: The long-term prognosis of non-alcoholic fatty liver disease (NAFLD) in children remains uncertain. We aimed at determining the long-term outcomes and survival of children with NAFLD. Design: Retrospective longitudinal hospital-based cohort study. Patients: Sixty-six children with NAFLD (mean age 13.9 (SD 3.9) years) were followed up for up to 20 years with a total of 409.6 person-years of follow-up. Results: The metabolic syndrome was present in 19 (29%) children at the time of NAFLD diagnosis with 55 (83%) presenting with at least one feature of the metabolic syndrome including obesity, hypertension, dyslipidaemia and/or hyperglycaemia. Four children with baseline normal fasting glucose developed type 2 diabetes 4–11 years after NAFLD diagnosis. A total of 13 liver biopsies were obtained from five patients over a mean of 41.4 (SD 28.8) months showing progression of fibrosis stage in four children. During follow-up, two children died and two underwent liver transplantation for decompensated cirrhosis. The observed survival free of liver transplantation was significantly shorter in the NAFLD cohort as compared to the expected survival in the general United States population of the same age and sex (log-rank test, p<0.00001), with a standardised mortality ratio of 13.6 (95% confidence interval, 3.8 to 34.8). NAFLD recurred in the allograft in the two cases transplanted, with one patient progressing to cirrhosis and requiring re-transplantation. Conclusions: Children with NAFLD may develop end-stage liver disease with the consequent need for liver transplantation. NAFLD in children seen in a tertiary care centre may be associated with a significantly shorter survival as compared to the general population.

[1]  P. O S I T I O N S T A T E M E N T,et al.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[2]  London,et al.  Editor's quiz: GI snapshot , 2010, British Journal of Ophthalmology.

[3]  M. Manco,et al.  Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis , 2008, International Journal of Obesity.

[4]  P. Socha,et al.  Recurrence of non‐alcoholic steatohepatitis after liver transplantation in a 13‐yr‐old boy , 2007, Pediatric Transplantation.

[5]  Y. K. Kim,et al.  The association of serum gamma glutamyltransferase with components of the metabolic syndrome in the Korean adults. , 2007, Diabetes research and clinical practice.

[6]  Jeffrey B. Schwimmer,et al.  Prevalence of Fatty Liver in Children and Adolescents , 2006, Pediatrics.

[7]  C. Sirlin,et al.  Pediatric Nonalcoholic Fatty Liver Disease: A Critical Appraisal of Current Data and Implications for Future Research , 2006, Journal of pediatric gastroenterology and nutrition.

[8]  M. Holmqvist,et al.  Long‐term follow‐up of patients with NAFLD and elevated liver enzymes , 2006, Hepatology.

[9]  P. Ciampalini,et al.  NAFLD in children: A prospective clinical‐pathological study and effect of lifestyle advice , 2006 .

[10]  E. Bernasconi,et al.  Severe large bowel obstruction secondary to infection with Actinomyces israelii , 2006, Scandinavian journal of infectious diseases.

[11]  R. Chien,et al.  Solitary actinomycotic abscesses of liver: report of two cases , 2005, International journal of clinical practice.

[12]  J. Noh,et al.  Serum γ‐glutamyltransferase within its normal concentration range is related to the presence of diabetes and cardiovascular risk factors , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[13]  S. Sanderson,et al.  The natural history of nonalcoholic fatty liver disease: a population-based cohort study. , 2005, Gastroenterology.

[14]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[15]  R. Deutsch,et al.  Influence of Gender, Race, and Ethnicity on Suspected Fatty Liver in Obese Adolescents , 2005, Pediatrics.

[16]  K. Lindor,et al.  Nonalcoholic fatty liver disease , 2005, Canadian Medical Association Journal.

[17]  D. Suzuki,et al.  LIVER FAILURE CAUSED BY NON‐ALCOHOLIC STEATOHEPATITIS IN AN OBESE YOUNG MALE , 2005, Journal of gastroenterology and hepatology.

[18]  M. Jonas,et al.  Rapid recurrence of nonalcoholic fatty liver disease after transplantation in a child with hypopituitarism and hepatopulmonary syndrome , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[19]  A. Baird Pelvic actinomycosis: still a cause for concern , 2005, Journal of Family Planning and Reproductive Health Care.

[20]  C. Lam,et al.  Hepatic steatosis in obese Chinese children , 2004, International Journal of Obesity.

[21]  K. Lindor,et al.  The Prevalence of Autoantibodies and Autoimmune Hepatitis in Patients with Nonalcoholic Fatty Liver Disease , 2004, American Journal of Gastroenterology.

[22]  P Christoffersen,et al.  Long term prognosis of fatty liver: risk of chronic liver disease and death , 2004, Gut.

[23]  K. Lindor,et al.  Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction , 2004, Hepatology.

[24]  R. Deutsch,et al.  Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. , 2003, The Journal of pediatrics.

[25]  K. Suzuki,et al.  Serum γ‐glutamyltransferase and development of impaired fasting glucose or type 2 diabetes in middle‐aged Japanese men , 2003, Journal of internal medicine.

[26]  E. Roberts,et al.  Nonalcoholic steatohepatitis in children , 2003, Current gastroenterology reports.

[27]  D. Jacobs,et al.  Gamma-glutamyltransferase and diabetes—a 4 year follow-up study , 2003, Diabetologia.

[28]  K. Nasu,et al.  Ureteral and Sigmoid Obstruction Caused by Pelvic Actinomycosis in an Intrauterine Contraceptive Device User , 2003, Gynecologic and Obstetric Investigation.

[29]  A. J. Bourne,et al.  Non‐alcoholic steatohepatitis in children and adolescents , 2000, The Medical journal of Australia.

[30]  H. Demir,et al.  Antiendomysium and antigliadin antibodies for the diagnosis of celiac disease. , 2000 .

[31]  F. Gürakan,et al.  Obesity: a cause of steatohepatitis in children. , 2000 .

[32]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions , 1999, American Journal of Gastroenterology.

[33]  M. Georgieff,et al.  Cholesterol in Childhood , 1998, Pediatrics.

[34]  F. Brunetti,et al.  Liver Involvement in Obese Children (Ultrasonography and Liver Enzyme Levels at Diagnosis and During Follow-up in an Italian Population) , 1997, Digestive Diseases and Sciences.

[35]  L. Melton,et al.  History of the Rochester Epidemiology Project. , 1996, Mayo Clinic proceedings.

[36]  A. Perez-Atayde,et al.  Idiopathic steatohepatitis in childhood: a multicenter retrospective study. , 1995, The Journal of pediatrics.

[37]  Yoshimasa Kusano,et al.  Prevalence of fatty liver in Japanese children and relationship to obesity , 1995, Digestive Diseases and Sciences.

[38]  J. C. Kim,et al.  Extensive colonic stricture due to pelvic actinomycosis. , 1995, Journal of Korean medical science.

[39]  K. Tsunamoto,et al.  Fatty liver and its fibrous changes found in simple obesity of children. , 1984, Journal of pediatric gastroenterology and nutrition.

[40]  J B Stokes,et al.  The national high blood pressure education program. , 1974, Journal of the American Pharmaceutical Association.

[41]  F. Ederer,et al.  The relative survival rate: a statistical methodology. , 1961, National Cancer Institute monograph.

[42]  Roger W. Byard,et al.  CDC Growth Charts , 2010 .

[43]  C. Day From fat to inflammation. , 2006, Gastroenterology.

[44]  J. Teckman,et al.  Obese children with steatohepatitis can develop cirrhosis in childhood , 2002, American Journal of Gastroenterology.

[45]  F. Gürakan,et al.  Obesity: a cause of steatohepatitis in children , 2000, American Journal of Gastroenterology.

[46]  A F Roche,et al.  CDC growth charts: United States. , 2000, Advance data.

[47]  F. Schaffner,et al.  Nonalcoholic fatty liver disease. , 1986, Progress in liver diseases.